Research and development - Press Releases

Date	Title	Company
22-Jul-2023	27th International Conference on Advanced Nanoscience and Nanotechnology	Allied Academies
21-Jul-2023	PRODUCTLIFE GROUP ACQUIRES RNI, EXPANDING ITS SCIENTIFIC AND REGULATORY OFFERING TO SELFCARE PRODUCTS	ProductLife Group (PLG)
21-Jul-2023	Toppan Holds VIRTUAL REMIX JAPAN™ Metaverse Event	Toppan
21-Jul-2023	Are shared medical appointments the key to solving global healthcare shortages?	ESMT Berlin
21-Jul-2023	The Science-Based Targets Initiative (SBTi) validates Almirall's 2030 emission reduction targets and its goal of achieving net zero emissions by 2050	Almirall
21-Jul-2023	Teva UK launches GoResp® Digihaler® (budesonide/ formoterol), the first integrated digital inhaler system for appropriate adult patients with asthma and COPD[i] in the UK	Teva UK Limited
21-Jul-2023	Researchers aim for rapid biomarker diagnostic test for stroke, using saliva	University of Birmingham
21-Jul-2023	HUTCHMED Receives Breakthrough Therapy Designation in China for Fruquintinib Combination with Sintilimab for Treatment of Advanced Endometrial Cancer, and Completes Enrollment of Registration Study	HUTCHMED
20-Jul-2023	Delve into the Cosmos with Confidence: T,C&A Lab Unveils Meteorite Identification and Testing Capabilities	T,C&A Lab
19-Jul-2023	A Comprehensive Study on Patient Perspectives and Preferences in the Adhesion Barrier Market	Markets and Markets
19-Jul-2023	CD Formulation: Advancing Pharmaceutical Analysis and Testing through Biological Determination	CD Formulation
18-Jul-2023	UNESCO to support more than 50 countries in designing an Ethical AI Policy this year	UNESCO
18-Jul-2023	The Lazarus Pit opens the doorway to all new alternative treatments for cancer	Eric Kikkert
18-Jul-2023	Domino to Unveil New Digital Retrofit Module for Hybrid Integration at Labelexpo Europe 2023	Domino
18-Jul-2023	Lifebit partners with Latin American innovators to help solve global health challenges through genomics research	Lifebit
18-Jul-2023	Mainz Biomed Announces Collaboration with Fugene Genetics in Israel	Mainz Biomed
18-Jul-2023	Elevar Therapeutics Announces FDA Acceptance for Filing of New Drug Application for Rivoceranib in Combination with Camrelizumab as a First-line Treatment for Unresectable Hepatocellular Carcinoma	Elevar Therapeutics
18-Jul-2023	Full Spectrum Integration: CD Formulation’s All-encompassing Solutions for Cosmetic Products	CD Formulation
17-Jul-2023	Alfa Chemistry: Custom Design Takes Organs-On-Chips to the Next Level	Alfa Chemistry
17-Jul-2023	Alfa Chemistry Newly Launches Proteomic Products for Life Science and Analytical Research	Alfa Chemistry